Ophthalmic manifestations in hematological malignancies: An observational study from a tertiary care health center in Eastern India
- PMID: 38189493
- PMCID: PMC11168555
- DOI: 10.4103/IJO.IJO_815_23
Ophthalmic manifestations in hematological malignancies: An observational study from a tertiary care health center in Eastern India
Abstract
Purpose: This study aimed to document the spectrum of ocular manifestations of hematological malignancies presenting to a tertiary health center in Eastern India and their association with blood parameters.
Methods: This hospital-based cross-sectional study was conducted from August 2021 to July 2022. Patients diagnosed with leukemia, lymphoma, and multiple myeloma were enrolled in the study. A comprehensive ophthalmic evaluation was done in each case.
Results: A total of 97 patients with a confirmed diagnosis of hematological malignancies and meeting the inclusion and exclusion criteria were included in the study. Ocular manifestations were noted in 48 (49.48%) patients. Acute lymphocytic leukemia accounted for 35.4% of cases, followed by acute myeloid leukemia (31.25%), lymphoma (4.2%), and minimum manifestation in multiple myeloma (2.1%) patients. Among 48 patients with ocular manifestations, anterior segment involvement was found in 6.2% of cases, with subconjunctival hemorrhage being the most common, and the posterior segment was involved in 100% of patients, with intraretinal hemorrhages being the most common manifestation. A statistically significant association was noted between hemoglobin, total red blood cell count, and total platelet count with posterior segment manifestations ( p < 0.001). On multivariable logistic regression, only total leucocyte count and total platelet count were significant predictors for ocular manifestation.
Conclusion: Indirect involvement of the retina is the most common ocular pathology in hematological malignancies, with intraretinal hemorrhages being the most common finding. Ophthalmic examination is highly recommended as a part of the routine evaluation at the time of diagnosis of hematological malignancies and periodically thereafter to diagnose any ocular involvement.
Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Ocular Manifestations in Leukemias and Their Correlation with Hematologic Parameters at a Tertiary Care Setting in South India.Ophthalmol Retina. 2018 Jan;2(1):17-23. doi: 10.1016/j.oret.2017.05.009. Epub 2017 Aug 5. Ophthalmol Retina. 2018. PMID: 31047297
-
Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters.Ann Afr Med. 2016 Jul-Sep;15(3):97-103. doi: 10.4103/1596-3519.188887. Ann Afr Med. 2016. PMID: 27549412 Free PMC article.
-
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters.Ann Hematol. 2024 Sep;103(9):3519-3533. doi: 10.1007/s00277-024-05861-2. Epub 2024 Jul 10. Ann Hematol. 2024. PMID: 38985179 Free PMC article.
-
[Ocular changes in primary hematologic diseases].Klin Monbl Augenheilkd. 1998 Jun;212(6):419-27. doi: 10.1055/s-2008-1034925. Klin Monbl Augenheilkd. 1998. PMID: 9715461 Review. German.
-
Ophthalmic manifestations of leukemia.Curr Opin Ophthalmol. 2016 Nov;27(6):545-551. doi: 10.1097/ICU.0000000000000309. Curr Opin Ophthalmol. 2016. PMID: 27585213 Review.
References
-
- Aisenberg AC. Historical review of lymphomas. Br J Haematol. 2000;109:466–76. - PubMed
-
- Reddy SC, Jackson N, Menon BS. Ocular involvement in leukemia--A study of 288 cases. Ophthalmologica. 2003;217:441–5. - PubMed
-
- Omoti AE, Omoti CE. Ophthalmic manifestations of multiple myeloma. West Afr J Med. 2007;26:265–8. - PubMed
-
- Singh AD. The prevalence of ocular disease in chronic lymphocytic leukemia. Eye (Lond) 2003;17:3–4. - PubMed